Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Gross Sales	$ 5,113,476	$ 5,375,630
Allowances	0	(225)
Total Net Sales	5,113,476	5,375,405
Cost of sales	1,712,867	1,817,907
Gross Profit	3,400,609	3,557,498
Operating expenses	3,486,881	4,623,333
Loss from operations	(86,272)	(1,065,835)
Decrease of contingent liability	0	69,752
Decrease (increase) in fair value of convertible debt	89,963	0
Interest expense	11,404	(418)
Income (loss) before provision for income taxes	15,095	(996,501)
Net Income (loss)	15,095	(996,501)
Preferred dividends	1,000,501	1,000,501
Net Loss attributable to cbdMD, Inc. common shareholders	$ (985,406)	$ (1,997,002)
Net Loss per share:
Basic and Diluted earnings per share (in dollars per share)	$ (0.22)	$ (0.67)
Weighted average number of shares Basic and Diluted: (in shares)	4,552,067	2,960,945